vs

Side-by-side financial comparison of POTLATCHDELTIC CORP (PCH) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $164.7M, roughly 1.9× PTC THERAPEUTICS, INC.). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs -82.0%, a 90.2% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs -22.7%). POTLATCHDELTIC CORP produced more free cash flow last quarter ($50.1M vs $-36.6M). Over the past eight quarters, POTLATCHDELTIC CORP's revenue compounded faster (11.1% CAGR vs -11.5%).

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

PCH vs PTCT — Head-to-Head

Bigger by revenue
PCH
PCH
1.9× larger
PCH
$314.2M
$164.7M
PTCT
Growing faster (revenue YoY)
PCH
PCH
+45.9% gap
PCH
23.1%
-22.7%
PTCT
Higher net margin
PCH
PCH
90.2% more per $
PCH
8.2%
-82.0%
PTCT
More free cash flow
PCH
PCH
$86.8M more FCF
PCH
$50.1M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
PCH
PCH
Annualised
PCH
11.1%
-11.5%
PTCT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
PCH
PCH
PTCT
PTCT
Revenue
$314.2M
$164.7M
Net Profit
$25.9M
$-135.0M
Gross Margin
18.2%
Operating Margin
11.2%
-43.3%
Net Margin
8.2%
-82.0%
Revenue YoY
23.1%
-22.7%
Net Profit YoY
682.5%
-104.8%
EPS (diluted)
$0.33
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCH
PCH
PTCT
PTCT
Q4 25
$164.7M
Q3 25
$314.2M
$211.0M
Q2 25
$275.0M
$178.9M
Q1 25
$268.3M
$1.2B
Q4 24
$258.1M
$213.2M
Q3 24
$255.1M
$196.8M
Q2 24
$320.7M
$186.7M
Q1 24
$228.1M
$210.1M
Net Profit
PCH
PCH
PTCT
PTCT
Q4 25
$-135.0M
Q3 25
$25.9M
$15.9M
Q2 25
$7.4M
$-64.8M
Q1 25
$25.8M
$866.6M
Q4 24
$5.2M
$-65.9M
Q3 24
$3.3M
$-106.7M
Q2 24
$13.7M
$-99.2M
Q1 24
$-305.0K
$-91.6M
Gross Margin
PCH
PCH
PTCT
PTCT
Q4 25
Q3 25
18.2%
Q2 25
13.0%
Q1 25
17.8%
Q4 24
13.4%
Q3 24
10.8%
Q2 24
11.9%
Q1 24
7.0%
Operating Margin
PCH
PCH
PTCT
PTCT
Q4 25
-43.3%
Q3 25
11.2%
1.4%
Q2 25
5.0%
-19.5%
Q1 25
10.3%
82.5%
Q4 24
5.2%
-76.2%
Q3 24
2.8%
-27.7%
Q2 24
5.4%
-21.5%
Q1 24
-2.1%
-21.6%
Net Margin
PCH
PCH
PTCT
PTCT
Q4 25
-82.0%
Q3 25
8.2%
7.5%
Q2 25
2.7%
-36.3%
Q1 25
9.6%
73.7%
Q4 24
2.0%
-30.9%
Q3 24
1.3%
-54.2%
Q2 24
4.3%
-53.1%
Q1 24
-0.1%
-43.6%
EPS (diluted)
PCH
PCH
PTCT
PTCT
Q4 25
$-1.63
Q3 25
$0.33
$0.20
Q2 25
$0.09
$-0.83
Q1 25
$0.33
$10.04
Q4 24
$0.07
$-0.85
Q3 24
$0.04
$-1.39
Q2 24
$0.17
$-1.29
Q1 24
$0.00
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCH
PCH
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$88.8M
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$-205.3M
Total Assets
$3.2B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCH
PCH
PTCT
PTCT
Q4 25
$1.9B
Q3 25
$88.8M
$1.7B
Q2 25
$95.3M
$2.0B
Q1 25
$147.5M
$2.0B
Q4 24
$151.6M
$1.1B
Q3 24
$161.1M
$1.0B
Q2 24
$199.7M
$1.1B
Q1 24
$180.2M
$884.8M
Total Debt
PCH
PCH
PTCT
PTCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PCH
PCH
PTCT
PTCT
Q4 25
$-205.3M
Q3 25
$1.9B
$-155.8M
Q2 25
$1.9B
$-206.5M
Q1 25
$2.0B
$-185.8M
Q4 24
$2.0B
$-1.1B
Q3 24
$2.1B
$-1.1B
Q2 24
$2.1B
$-980.2M
Q1 24
$2.2B
$-893.9M
Total Assets
PCH
PCH
PTCT
PTCT
Q4 25
$2.9B
Q3 25
$3.2B
$2.6B
Q2 25
$3.2B
$2.6B
Q1 25
$3.3B
$2.7B
Q4 24
$3.3B
$1.7B
Q3 24
$3.3B
$1.8B
Q2 24
$3.4B
$1.9B
Q1 24
$3.4B
$1.8B
Debt / Equity
PCH
PCH
PTCT
PTCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.51×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCH
PCH
PTCT
PTCT
Operating Cash FlowLast quarter
$65.7M
$-34.3M
Free Cash FlowOCF − Capex
$50.1M
$-36.6M
FCF MarginFCF / Revenue
15.9%
-22.3%
Capex IntensityCapex / Revenue
4.9%
1.4%
Cash ConversionOCF / Net Profit
2.54×
TTM Free Cash FlowTrailing 4 quarters
$132.4M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCH
PCH
PTCT
PTCT
Q4 25
$-34.3M
Q3 25
$65.7M
$-66.3M
Q2 25
$41.0M
$-58.3M
Q1 25
$49.1M
$870.1M
Q4 24
$45.4M
$-30.0M
Q3 24
$26.5M
$-77.0M
Q2 24
$100.6M
$-71.5M
Q1 24
$16.0M
$70.8M
Free Cash Flow
PCH
PCH
PTCT
PTCT
Q4 25
$-36.6M
Q3 25
$50.1M
$-69.7M
Q2 25
$30.6M
$-59.6M
Q1 25
$26.3M
$868.4M
Q4 24
$25.4M
$-33.8M
Q3 24
$-8.2M
$-77.5M
Q2 24
$72.4M
$-78.8M
Q1 24
$2.0M
$61.2M
FCF Margin
PCH
PCH
PTCT
PTCT
Q4 25
-22.3%
Q3 25
15.9%
-33.1%
Q2 25
11.1%
-33.3%
Q1 25
9.8%
73.8%
Q4 24
9.9%
-15.8%
Q3 24
-3.2%
-39.4%
Q2 24
22.6%
-42.2%
Q1 24
0.9%
29.1%
Capex Intensity
PCH
PCH
PTCT
PTCT
Q4 25
1.4%
Q3 25
4.9%
1.6%
Q2 25
3.8%
0.7%
Q1 25
8.5%
0.1%
Q4 24
7.7%
1.8%
Q3 24
13.6%
0.3%
Q2 24
8.8%
4.0%
Q1 24
6.1%
4.6%
Cash Conversion
PCH
PCH
PTCT
PTCT
Q4 25
Q3 25
2.54×
-4.17×
Q2 25
5.58×
Q1 25
1.90×
1.00×
Q4 24
8.74×
Q3 24
7.99×
Q2 24
7.35×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons